Patent · US Active

Isolated monoclonal anti-repulsive guidance molecule A antibodies and uses thereof

US10106602B2 · kind B2 · utility

1Cited by

166References

11Claims

0Family size

Assignees

Abb Vie Deutschland Gmbh & Co. KG · DE
Abb Vie Inc. · US

Inventors

Bernhard Mueller · Neustadt, DE
Lili Huang · Westford, US
Philip Bardwell · Boston, US
Yuliya Kutskova · Northborough, US
John E. Memmott · Framingham, US

Key dates

Filing date	May 16, 2016
Grant date	Oct 23, 2018
Priority date	—
Expiry date	Jun 2, 2036

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/285
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are anti-Repulsive Guidance Molecule a (RGMa) antibodies and methods of using the antibodies to treat and diagnose neurite degenerative diseases and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.